(IR) Ingersoll Rand - Overview
Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: NYSE (USA) | Market Cap: 27.750m USD | Total Return: -14% in 12m
Avg Turnover: 284M
EPS Trend: 84.3%
Qual. Beats: 0
Rev. Trend: 98.6%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Ingersoll Rand Inc. (IR) is a global provider of mission-critical flow creation and industrial solutions. The company operates through two primary divisions: Industrial Technologies and Services, which focuses on air compression and vacuum systems, and Precision and Science Technologies, which specializes in niche pumping and liquid handling systems for medical and laboratory applications.
The business model relies heavily on a razor-and-blade strategy, where the large installed base of complex machinery generates high-margin recurring revenue through aftermarket parts, consumables, and maintenance services. This industrial machinery sector is currently characterized by a shift toward energy-efficient systems as global manufacturers seek to reduce carbon footprints and operational costs.
The company maintains a diverse brand portfolio, including Gardner Denver and Milton Roy, serving fragmented end-markets such as water treatment, clean energy, and chemical processing. Investors may find it useful to review ValueRay for a deeper dive into these segments. Originally founded in 1859, the current entity was formed following the 2020 merger between Gardner Denver Holdings and the industrial segment of the former Ingersoll-Rand plc.
- Industrial automation demand drives organic revenue growth in core manufacturing segments
- Aftermarket services and consumables provide high-margin recurring cash flow stability
- Strategic acquisitions and portfolio optimization accelerate expansion into high-growth end markets
- Global industrial production levels and capital expenditure cycles dictate equipment order volume
- Hydrogen compression and clean energy transition create long-term precision technology demand
| Net Income: 587.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -1.41 > 1.0 |
| NWC/Revenue: 30.38% < 20% (prev 34.67%; Δ -4.30% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.30b > Net Income 587.0m |
| Net Debt (3.57b) to EBITDA (1.66b): 2.16 < 3 |
| Current Ratio: 2.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (392.0m) vs 12m ago -3.72% < -2% |
| Gross Margin: 38.24% > 18% (prev 0.44%; Δ 3.78k% > 0.5%) |
| Asset Turnover: 42.52% > 50% (prev 39.62%; Δ 2.90% > 0%) |
| Interest Coverage Ratio: 4.53 > 6 (EBITDA TTM 1.66b / Interest Expense TTM 256.5m) |
| A: 0.13 (Total Current Assets 4.29b - Total Current Liabilities 1.93b) / Total Assets 18.2b |
| B: 0.18 (Retained Earnings 3.24b / Total Assets 18.2b) |
| C: 0.06 (EBIT TTM 1.16b / Avg Total Assets 18.3b) |
| D: 0.38 (Book Value of Equity 3.05b / Total Liabilities 7.98b) |
| Altman-Z'' = 2.26 = BBB |
| DSRI: 1.01 (Receivables 1.46b/1.35b, Revenue 7.78b/7.28b) |
| GMI: 1.15 (GM 38.24% / 43.80%) |
| AQI: 1.00 (AQ_t 0.71 / AQ_t-1 0.72) |
| SGI: 1.07 (Revenue 7.78b / 7.28b) |
| TATA: -0.04 (NI 587.0m - CFO 1.30b) / TA 18.2b) |
| Beneish M = -2.88 (Cap -4..+1) = A |
As of May 28, 2026, the stock is trading at USD 70.96 with a total of 3,809,956 shares traded.
Over the past week, the price has changed by +3.53%,
over one month by -15.51%,
over three months by -24.59% and
over the past year by -14.00%.
Ingersoll Rand has received a consensus analysts rating of 3.94. Therefore, it is recommended to buy IR.
- StrongBuy: 7
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 94 | 32.5% |
P/E Trailing = 47.9122
P/E Forward = 20.4918
P/S = 3.5662
P/B = 2.7272
P/EG = 0.6764
Revenue TTM = 7.78b USD
EBIT TTM = 1.16b USD
EBITDA TTM = 1.66b USD
Long Term Debt = 4.78b USD (from longTermDebt, last quarter)
Short Term Debt = 1.40m USD (from shortTermDebt, last quarter)
Debt = 4.84b USD (corrected: LT Debt 4.78b + ST Debt 1.40m) + Leases 64.8m
Net Debt = 3.57b USD (calculated: Debt 4.84b - CCE 1.27b)
Enterprise Value = 31.3b USD (27.7b + Debt 4.84b - CCE 1.27b)
Interest Coverage Ratio = 4.53 (Ebit TTM 1.16b / Interest Expense TTM 256.5m)
EV/FCF = 26.98x (Enterprise Value 31.3b / FCF TTM 1.16b)
FCF Yield = 3.71% (FCF TTM 1.16b / Enterprise Value 31.3b)
FCF Margin = 14.92% (FCF TTM 1.16b / Revenue TTM 7.78b)
Net Margin = 7.54% (Net Income TTM 587.0m / Revenue TTM 7.78b)
Gross Margin = 38.24% ((Revenue TTM 7.78b - Cost of Revenue TTM 4.81b) / Revenue TTM)
Gross Margin QoQ = 42.90% (prev 24.06%)
Tobins Q-Ratio = 1.72 (Enterprise Value 31.3b / Total Assets 18.2b)
Interest Expense / Debt = 5.30% (Interest Expense 256.5m / Debt 4.84b)
Taxrate = 15.70% (36.1m / 229.9m)
NOPAT = 980.2m (EBIT 1.16b * (1 - 15.70%))
Current Ratio = 2.23 (Total Current Assets 4.29b / Total Current Liabilities 1.93b)
Debt / Equity = 0.48 (Debt 4.84b / totalStockholderEquity, last quarter 10.2b)
Debt / EBITDA = 2.16 (Net Debt 3.57b / EBITDA 1.66b)
Debt / FCF = 3.07 (Net Debt 3.57b / FCF TTM 1.16b)
Total Stockholder Equity = 10.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.21% (Net Income 587.0m / Total Assets 18.2b)
RoE = 5.80% (Net Income TTM 587.0m / Total Stockholder Equity 10.1b)
RoCE = 7.81% (EBIT 1.16b / Capital Employed (Equity 10.1b + L.T.Debt 4.78b))
RoIC = 6.34% (NOPAT 980.2m / Invested Capital 15.5b)
WACC = 9.38% (E(27.7b)/V(32.6b) * Re(10.24%) + D(4.84b)/V(32.6b) * Rd(5.30%) * (1-Tc(0.16)))
Discount Rate = 10.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.61 | Cagr: -1.65%
[DCF] Terminal Value 69.33% ; FCFF base≈1.27b ; Y1≈1.11b ; Y5≈898.9m
[DCF] Fair Price = 22.39 (EV 12.3b - Net Debt 3.57b = Equity 8.76b / Shares 391.3m; r=9.38% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 84.32 | EPS CAGR: 7.09% | SUE: 0.53 | # QB: 0
Revenue Correlation: 98.60 | Revenue CAGR: 6.16% | SUE: 0.58 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.83 | Chg30d=-3.70% | Revisions=-76% | Analysts=15
EPS next Quarter (2026-09-30): EPS=0.91 | Chg30d=-0.97% | Revisions=-33% | Analysts=15
EPS current Year (2026-12-31): EPS=3.50 | Chg30d=-0.41% | Revisions=-25% | GrowthEPS=+4.9% | GrowthRev=+3.8%
EPS next Year (2027-12-31): EPS=3.85 | Chg30d=-0.64% | Revisions=-60% | GrowthEPS=+9.8% | GrowthRev=+4.6%
[Analyst] Revisions Ratio: -76%